Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia

American Journal of Tropical Medicine and Hygiene

Volumn 75, Issue 4, 2006, Pages 605-609

  Álvarez, Gonzalo ^a   Piñeros, Juan Gabriel ^a   Tobón, Alberto ^a   Ríos, Alexandra ^a   Maestre, Amanda ^a   Blair, Silvia ^a   Carmona Fonseca, Jaime ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; PRIMAQUINE; ANTIMALARIAL AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COLOMBIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; OPEN STUDY; PLASMODIUM VIVAX; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RELAPSE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ANIMAL; PARASITEMIA; PROSPECTIVE STUDY;

PLASMODIUM VIVAX;

ADULT; ANIMALS; ANTIMALARIALS; CHLOROQUINE; COLOMBIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALARIA, VIVAX; MALE; PARASITEMIA; PRIMAQUINE; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME;

EID: 33750605813     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2006.75.605     Document Type: Article

References (21)

1. Suh KN, Kain KC, Keystone JS, 2004. Malaria. CMAJ 170: 1693-1702.
2. Mendis K, Sina BJ, Marchesini P, Carter R, 2001. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64: 97-106.
3. Carmona J, 2003. La malaria en Colombia, Antioquia y las zonas de Urabá y Bajo Cauca: panorama para interpretar la falla terapéutica antimalárica. Parte 1. Iatreia 16: 299-318.
4. Soto J, Toledo J, Gutierrez P, Luzz M, Llinas N, Cedeno N, Dunne M, Berman J, 2001. Plasmodium vivax clinically resistant to chloroquine in Colombia. Am J Trop Med Hyg 65: 90-93.
5. Blair S, Tobón A, Echeverri M, Alvarez G, Carmona J, 2002. Adecuada respuesta clínica y parasitológica de Plasmodium vivax a la cloroquina en Colombia (Turbo, Antioquia), 2001. Infectio 6: 21-26.
6. World Health Organization, 1990. Practical chemotherapy of malaria. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser 805: 1-141.
7. Beutler E, 1997. Glucose-6-phospate dehydrogenase deficiency, diagnosis, clinical and genetic implications. Am J Clin Pathol 47: 1967.
8. Baird JK, Rieckmann KH, 2003. Can primaquine therapy for vivax malaria be improved? Trends Parasitol 19: 115-120.
9. Gogtay N, Garg M, Kadam V, Kamtekar K, Kshirsagar NA, 1998. A 5 days primaquine regimen as anti-relapse therapy for Plasmodium vivax. Trans R Soc Trop Med Hyg 92: 341.
10. Abdon NP, Pinto AY, das Silva Rdo S, de Souza JM, 2001. Assessment of the response to reduced treatment schemes for vivax malaria. Rev Soc Bras Med Trop 34: 343-348.
11. Bunnag D, Karbwang J, Thanavibul A, Chittamas S, Ratanapongse Y, Chalermrut K, Bangchang KN, Harinasuta T, 1994. High dose of primaquine in primaquine resistant vivax malaria. Trans R Soc Trop Med Hyg 88: 218-219.
12. Bergonzoli G, Rivers Cuadra JC, 2000. Therapeutic efficacy of different antimalarial regimens in the Costa Rica-Nicaragua border region. Rev Panam Salud Publico 7: 366-370.
13. Lacharme L, Carmona J, Tobon A, Blair S, 1998. Respuesta de P. vivax al esquema terapéutico cloroquina-primaquina en Zaragoza y Turbo, Colombia. Infectio 2: 90-94.
14. Lwanga SK, Lameshow S, 1991. Determinación del Tamaño Muestral en los Estudios Sanitarios. Manual Prático. Geneva: World Health Organization.
15. World Health Organization, 2000. Severe falciparum malaria. Trans R Soc Trop Med Hyg 94 (Suppl 1): 1-90.
16. Alecrim Md G, Alecrim W, Macedo V, 1999. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region. Rev Soc Bras Med Trop 32: 67-68.
17. Phillips EJ, Keystone JS, Kain KC, 1996. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clin Infect Dis 23: 1171-1173.
18. Ruebush TK 2nd, Zegarra J, Cairo J, Andersen EM, Green M, Pillai DR, Marquino W, Huilca M, Arevalo E, Garcia C, Solary L, Kain KC, 2003. Chloroquine-resistant Plasmodium vivax malaria in Peru. Am J Trop Med Hyg 69: 548-552.
19. Baird JK, Hoffman SL, 2004. Primaquine therapy for malaria. Clin Infect Dis 39: 1336-1345.
20. Duarte EC, Pang LW, Ribeiro LC, Fontes CJ, 2001. Association of subtherapeutic dosages of a standard drug regimen with failures in preventing relapses of vivax malaria. Am J Trop Med Hyg 65: 471-476.
21. Schwartz E, Regev-Yochay G, Kurnik D, 2000. Short report: a consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria. Am J Trop Med Hyg 62: 393-395.